Identification of alpha- and beta-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy.
Abstract
BACKGROUND
Immunization with cardiac myosin induces experimental autoimmune heart disease in genetically predisposed mice. These mice produce heart-specific autoantibodies, some of which are directed against the cardiac myosin isoform.
METHODS AND RESULTS
We have reported the presence of circulating heart-specific autoantibodies in 26% of patients with idiopathic dilated cardiomyopathy (DCM) using indirect immunofluorescence. To identify the autoantigen(s) recognized by heart-specific autoantibodies in human disease, we tested, by Western blotting, sera from 26 DCM patients, 14 of whom were cardiac antibody-positive and 12 antibody-negative, as well as sera from 12 patients with cardiac failure from ischemic or valvular heart disease and from 13 normal subjects who were cardiac antibody-negative. Crude myofibrillar proteins and myosin preparations extracted from human atrial or ventricular specimens were used as antigens. Sodium dodecyl sulfate polyacrylamide gel electrophoresis was performed. The proteins were electrophoretically transferred to nitrocellulose sheets. The paper strips were incubated in sera from patients or controls at 1:100 dilution; the reaction was revealed with a peroxidase-labeled second antibody against human immunoglobulin. Twelve of the 14 DCM sera (86%) containing heart-specific antibodies reacted with both the alpha- (atrial specific) and beta- (ventricular and slow skeletal) myosin heavy chain isoforms; none of the 13 normal sera (p = 0.0001) and one of the 24 heart failure-negative control sera (4%, p = 0.0001) contained antibodies against myosin heavy chain.
CONCLUSIONS
These findings indicate that alpha- and beta-cardiac myosin heavy chain isoforms as in the murine model of autoimmune heart disease are major autoantigens in patients with idiopathic DCM.
Formats available
You can view the full content in the following formats:
Information & Authors
Information
Published In
Copyright
Copyright © 1992 by American Heart Association.
History
Published online: 1 May 1992
Published in print: May 1992
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
- Immunomodulating and Immunosuppressive Therapy for Virus-Negative Immune-Mediated Myocarditis, Biomedicines, 12, 7, (1565), (2024).https://doi.org/10.3390/biomedicines12071565
- The Role of the Immune System in Pathobiology and Therapy of Myocarditis: A Review, Biomedicines, 12, 6, (1156), (2024).https://doi.org/10.3390/biomedicines12061156
- Polymorphisms of CD247 gene is associated with dilated cardiomyopathy in Chinese Han population, BMC Cardiovascular Disorders, 24, 1, (2024).https://doi.org/10.1186/s12872-024-04160-y
- Autoimmune Myocarditis, Old Dogs and New Tricks, Circulation Research, 134, 12, (1767-1790), (2024)./doi/10.1161/CIRCRESAHA.124.323816
- Role of T Cells in Viral and Immune-mediated Myocarditis, Cardiology Discovery, 4, 1, (43-54), (2024).https://doi.org/10.1097/CD9.0000000000000116
- Novel insights into cardiovascular toxicity of cancer targeted and immune therapies: Beyond ischemia with non-obstructive coronary arteries (INOCA), American Heart Journal Plus: Cardiology Research and Practice, 40, (100374), (2024).https://doi.org/10.1016/j.ahjo.2024.100374
- Myocarditis and dilated cardiomyopathy, The Rose and Mackay Textbook of Autoimmune Diseases, (955-967), (2024).https://doi.org/10.1016/B978-0-443-23947-2.00032-1
- Genetic and immunogenetic basis of myocarditis, Genomic and Molecular Cardiovascular Medicine, (87-104), (2024).https://doi.org/10.1016/B978-0-12-822951-4.00006-0
- Functions and Clinical Significance of Myocardial Cell-Derived Immunoglobulins, Non B cell-Derived Immunoglobulins, (119-128), (2024).https://doi.org/10.1007/978-981-97-0511-5_9
- Cardiovascular Diseases, Manual of Molecular and Clinical Laboratory Immunology, (1054-1070), (2024).https://doi.org/10.1002/9781683674023.ch95
- See more
Loading...
View Options
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to access the full text.
eLetters(0)
eLetters should relate to an article recently published in the journal and are not a forum for providing unpublished data. Comments are reviewed for appropriate use of tone and language. Comments are not peer-reviewed. Acceptable comments are posted to the journal website only. Comments are not published in an issue and are not indexed in PubMed. Comments should be no longer than 500 words and will only be posted online. References are limited to 10. Authors of the article cited in the comment will be invited to reply, as appropriate.
Comments and feedback on AHA/ASA Scientific Statements and Guidelines should be directed to the AHA/ASA Manuscript Oversight Committee via its Correspondence page.